Free Trial

BioNTech (BNTX) SEC Filings & 10K Form

BioNTech logo
$99.09 -2.63 (-2.59%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$98.71 -0.38 (-0.39%)
As of 05/21/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent BioNTech SEC Filings

DateFilerForm TypeView
05/20/2025
7:58 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2025
5:14 PM
BioNTech (Subject)
Medine GmbH (Filed by)
Form SCHEDULE 13G/A
05/07/2025
6:30 AM
BioNTech (Subject)
Jeggle Helmut Wolfgang (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
6:33 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2025
5:53 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/05/2025
5:33 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2025
6:54 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
5:57 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
6:00 AM
BioNTech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/27/2025
6:57 AM
BioNTech (Subject)
Richardson Ryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
6:53 AM
BioNTech (Subject)
Medine GmbH (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
6:50 AM
BioNTech (Subject)
Poetting Sierk (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:02 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2025
5:58 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2024
6:25 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2024
6:21 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2024
4:56 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
4:25 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
5:35 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2024
4:57 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
4:50 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
5:37 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
4:06 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
6:38 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
5:49 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
5:53 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
5:57 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/18/2024
8:04 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
4:03 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
7:41 AM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:15 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
3:13 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
3:24 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:17 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
4:14 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
5:18 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
7:12 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
3:52 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/27/2024
4:12 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/25/2024
6:14 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
8:17 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)

Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
09/18/2024
6:28 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:35 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
7:53 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/22/2024
3:31 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
7:34 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/16/2024
5:56 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/05/2024
5:32 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/05/2024
5:34 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
8:08 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:07 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
6:18 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
6:46 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
3:36 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BNTX) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners